PRICE T ROWE ASSOCIATES INC /MD/
Position in SNDX — Syndax Pharmaceuticals Inc
CIK 80255
BALTIMORE, MD
Position in SNDX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,802,430
+$299,804 QoQ
Shares Held
128,199
+19.7% QoQ
Ownership
0.144%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#89
of 242 holders
Holding Since
Dec 2020
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SNDX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PRICE T ROWE ASSOCIATES INC /MD/ holds $17,555,962,932 across 304 Biotechnology names. SNDX ranks #141 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
2,678,047 | $2,484,611,664 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,529,709 | $953,834,749 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,728,421 | $858,558,562 | |
| 4 | KYMR |
Kymera Therapeutics, Inc.
|
7,112,980 | $815,645,416 | |
| 5 | RPRX |
Royalty Pharma plc
|
11,193,657 | $627,628,347 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
2,969,853 | $447,655,945 | |
| 7 | MRNA |
Moderna, Inc.
|
5,589,560 | $391,436,886 | |
| 8 | SRRK |
Scholar Rock Holding Corp
|
6,794,837 | $373,716,035 |
All Filings in SNDX
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,802,430 | 128,199 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $2,502,626 | 107,133 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $1,992,357 | 94,829 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $1,402,096 | 91,134 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $706,158 | 75,404 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $812,210 | 66,114 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $753,791 | 57,019 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $941,844 | 48,927 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $989,504 | 48,198 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $1,059,338 | 44,510 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $567,629 | 26,267 | Shares | Defined | 2024-02-16 | |
| 2023-09-30 | $354,433 | 24,410 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $480,113 | 22,939 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $240,007 | 11,364 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $238,313 | 9,364 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $202,548 | 8,429 | Shares | Defined | 2022-11-14 | |
| 2021-09-30 | $9,862,632 | 516,098 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $7,218,611 | 420,420 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $9,816,420 | 439,017 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $3,812,803 | 171,439 | Shares | Sole | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||